Medication info

SmofKabiven Peripheral

Prescription medicationSolutionInjection
Ingredient · strength
L-Alanine›14gL-Arginine›12gGlycine›11gL-Histidine›3gL-Isoleucine›5gL-Leucine›7.4gL-Lysine Acetate›9.3gL-Methionine›4.3gL-Phenylalanine›5.1gL-Proline›11.2gL-Serine›6.5gTaurine›1gL-Threonine›4.4gL-Tryptophan›2gL-Tyrosine›0.4gL-Valine›6.2gCalcium Chloride Hydrate›0.74gAnhydrous Sodium Glycerophosphate›4.18gMagnesium Sulfate Heptahydrate›2.47gPotassium Chloride›4.48gSodium Acetate Hydrate›5.62gZinc Sulfate Heptahydrate›0.023gGlucose Monohydrate›143gSoybean Oil›60gTriglycerides Medium-Chain›60gPurified Olive Oil›50gPurified Fish Oil (High Dose Omega-3 Fatty Acids)›30g
Manufacturer / importer
Fresenius Kabi Korea Ltd.
Appearance
This medication consists of a plastic material container divided into three compartments, with an oxygen absorber placed between them. Each inner compartment contains an amino acid and electrolyte solution.
Packaging
1206 mL/bag [(A solution 380 mL, B solution 656 mL, C solution 170 mL) x 4], 1448 mL/bag [(A solution 456 mL, B solution 788 mL, C solution 204 mL) x 4], 1904 mL/bag [(A solution 600 mL, B solution 1036 mL, C solution 268 mL) x 4]
Approval status
Active

MFDS item code 200906855 · Approved 2009.09.11 · Insurance code 650901620,650901630,650901640

Summary

Main use
Improvement of nutritional status by supplying parenteral nutrition (calories, amino acids, essential fatty acids, etc.)
Who receives it
Adults · Children
Adult administration
The dose and infusion rate are determined according to the patient's ability to eliminate fat, metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized, taking into account the patient's condition, body weight, nutritional and energy requirements, and additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc., may be added depending on the patient's condition. Nitrogen requirements to maintain body protein depend on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: 0.6-0.9 g/kg/day as amino acids (0.10-0.15 g/kg/day as nitrogen) - Patients experiencing moderate to severe metabolic stress, regardless of nutritional imbalance: 0.9-1.6 g/kg/day as amino acids (0.15-0.25 g/kg/day as nitrogen) In very special cases (e.g., burns or marked anabolism), the nitrogen dose may be higher. Dose A daily dose of 20-40 mL/kg of this product corresponds to 0.6-1.3 g/kg of amino acids (0.10-0.20 g/kg as nitrogen) and total calories of 14-28 kcal/kg (non-protein calories of 11-22 kcal/kg). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to 0.10 g/kg amino acids, 0.21 g/kg glucose, and 0.08 g/kg fat). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40 mL/kg provides 1.3 g/kg of amino acids (0.20 g/kg as nitrogen), 2.8 g/kg of glucose, 1.1 g/kg of fat, and total calories of 28 kcal/kg (equivalent to 22 kcal/kg as non-protein calories). Administration Administer by intravenous infusion through a peripheral or central vein.
Child administration
Children 2-11 years Dose Pediatric patients have greater variability than adult patients; administer up to 40 mL/kg per day of this product, with regular adjustment according to requirements. Infusion rate The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to 0.10 g/kg amino acids, 0.21 g/kg glucose, and 0.08 g/kg fat). The recommended infusion duration is 12-24 hours. When administering the recommended maximum daily dose, infuse over at least 13 hours, except in special circumstances. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40 mL/kg provides 1.3 g/kg of amino acids (0.2 g/kg as nitrogen), 2.8 g/kg of glucose, 1.1 g/kg of fat, and total calories of 28 kcal/kg (equivalent to 22 kcal/kg as non-protein calories).

Ingredients

Importer
Fresenius Kabi Korea Ltd.

Efficacy & effects

Improvement of nutritional status by supplying parenteral nutrition (calories, amino acids, essential fatty acids, etc.)

View approved original text

This medication is used for supplying calories, amino acids, essential fatty acids, and Omega-3 fatty acids to children over 2 years old and adults when oral intake or gastrointestinal nutrition is insufficient or impossible. It helps improve the nutritional status of the patient and effectively provide the necessary nutrients. It is mainly utilized for nutritional therapy administered intravenously.

How it is given

Adult administration

The dose and infusion rate are determined according to the patient's ability to eliminate fat, metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized, taking into account the patient's condition, body weight, nutritional and energy requirements, and additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc., may be added depending on the patient's condition. Nitrogen requirements to maintain body protein depend on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: 0.6-0.9 g/kg/day as amino acids (0.10-0.15 g/kg/day as nitrogen) - Patients experiencing moderate to severe metabolic stress, regardless of nutritional imbalance: 0.9-1.6 g/kg/day as amino acids (0.15-0.25 g/kg/day as nitrogen) In very special cases (e.g., burns or marked anabolism), the nitrogen dose may be higher. Dose A daily dose of 20-40 mL/kg of this product corresponds to 0.6-1.3 g/kg of amino acids (0.10-0.20 g/kg as nitrogen) and total calories of 14-28 kcal/kg (non-protein calories of 11-22 kcal/kg). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to 0.10 g/kg amino acids, 0.21 g/kg glucose, and 0.08 g/kg fat). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40 mL/kg provides 1.3 g/kg of amino acids (0.20 g/kg as nitrogen), 2.8 g/kg of glucose, 1.1 g/kg of fat, and total calories of 28 kcal/kg (equivalent to 22 kcal/kg as non-protein calories). Administration Administer by intravenous infusion through a peripheral or central vein.

Child administration

Children 2-11 years Dose Pediatric patients have greater variability than adult patients; administer up to 40 mL/kg per day of this product, with regular adjustment according to requirements. Infusion rate The infusion rate must not exceed 3.0 mL/kg per hour (equivalent to 0.10 g/kg amino acids, 0.21 g/kg glucose, and 0.08 g/kg fat). The recommended infusion duration is 12-24 hours. When administering the recommended maximum daily dose, infuse over at least 13 hours, except in special circumstances. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40 mL/kg provides 1.3 g/kg of amino acids (0.2 g/kg as nitrogen), 2.8 g/kg of glucose, 1.1 g/kg of fat, and total calories of 28 kcal/kg (equivalent to 22 kcal/kg as non-protein calories).

Precautions

This medication must be used under a doctor's guidance and should not be taken arbitrarily based on self-judgment. If symptoms of anaphylactic reactions such as fever, chills, rash, or respiratory distress occur during use, administration should be immediately discontinued and medical advice sought. When administered with intravenous infusion solutions containing calcium, precipitation may occur; thus, care must be taken not to use the same infusion equipment. Particularly, in the case of premature or low birth weight infants, the metabolism of lipids may not be smooth, making the use of this medication potentially risky, requiring careful judgement. Patients with allergies to fish, eggs, soybeans, peanuts, or severe problems related to the liver, kidneys, or blood coagulation should not use this medication. Patients with certain conditions such as renal failure, diabetes, or liver dysfunction require additional caution when administering this medication, and their condition must be closely monitored. During administration, blood lipid levels and liver enzyme levels should be regularly monitored to detect adverse reactions early, and the dosage should be adjusted or discontinued if necessary. In case of overdose, symptoms such as nausea, vomiting, chills, and hyperglycemia may occur; if these symptoms arise, medical personnel should be informed immediately. This medication contains soybean oil, fish oil, and egg yolk lipids which could occasionally cause allergic reactions; therefore, caution is necessary. For pregnant or breastfeeding women, the safety of this medication has not been established, hence it should only be administered when the benefits outweigh the risks. During administration, maintaining asterile conditions is crucial to minimize infection risk, and the condition of the administration site should be frequently checked to prevent thrombosis or inflammation. Long-term use of this medication may necessitate management of trace element balance in nutritional status, and regular monitoring of blood sugar and electrolyte status is warranted. If packaging is damaged or the contents appear turbid or separated, do not use, and any unused solution should be discarded immediately after mixing. This medication should be stored in a tightly sealed container to avoid exposure to air, kept in a cool place below 25 degrees Celsius. Additionally, precautions should be taken to prevent the medication from freezing.

Side effects

  • fever
  • chills
  • rash
  • shortness of breath
  • tachycardia
  • loss of appetite
  • nausea
  • vomiting
  • increased plasma enzyme levels
  • thrombophlebitis
Show 113 more
  • hypotension
  • hypertension
  • mild elevation of body temperature
  • headache
  • dizziness
  • anaphylactic or anaphylactoid reactions
  • skin rash
  • urticaria
  • flushing
  • warmth
  • coldness
  • cyanosis
  • pallor
  • pain (neck, back, bone, chest, waist)
  • hyperlipidemia
  • fever
  • fat infiltration
  • jaundice
  • hepatomegaly
  • splenomegaly
  • anemia
  • leukopenia
  • thrombocytopenia
  • coagulopathy
  • hemolysis
  • reticulocytosis
  • abnormal liver function test results
  • coma
  • nausea
  • sweating
  • elevated body temperature
  • hyperglycemia
  • allergic reactions
  • constipation
  • diarrhea
  • pneumonia
  • stomatitis
  • delirium
  • dyspepsia
  • abdominal pain
  • hypoalbuminemia
  • insomnia
  • febrile neutropenia
  • general weakness
  • edema
  • urinary disorders
  • hematuria
  • weight loss
  • hypoglycemia
  • hypocalcemia
  • heartburn
  • aspiration pneumonia
  • hematemesis
  • runny nose
  • extravasation at the infusion site
  • phlebitis
  • procedure site reactions
  • urinary difficulties
  • cough
  • infection
  • thromboembolism
  • melena
  • vasculitis
  • skin infection
  • pulmonary edema
  • sepsis
  • Clostridium infection
  • candidiasis
  • dental diseases
  • pancreatitis
  • weight gain
  • fluid overload
  • spinal compression
  • vaginal bleeding
  • interstitial fluid retention
  • hyponatremia
  • bowel obstruction
  • cervical cancer
  • gum bleeding
  • pharyngeal diseases
  • depression
  • pressure sores
  • urinary incontinence
  • urinary tract infection
  • malnutrition
  • laceration
  • gastroesophageal reflux disease
  • aspergillosis
  • oral thrush
  • neuropathic pain
  • neuropathy
  • esophagitis
  • vesicles
  • wound infection
  • epigastric pain
  • frequent urination
  • anxiety
  • ascites
  • abdominal discomfort
  • atelectasis
  • peripheral neuropathy
  • hiccups
  • colitis
  • leg edema
  • cerebral ischemia
  • acute renal failure
  • myalgia
  • hypersensitivity
  • exacerbation of hypertension
  • conjunctival hemorrhage
  • hemoptysis
  • sputum disease
  • voice disorders

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid contact with air and kept in a cool place below 25 degrees Celsius. Additionally, care must be taken to prevent the medication from freezing.

Appearance and packaging

Appearance

This medication consists of a plastic material container divided into three compartments, with an oxygen absorber placed between them. Each inner compartment contains an amino acid and electrolyte solution.

Package unit

1206 mL/bag [(A solution 380 mL, B solution 656 mL, C solution 170 mL) x 4], 1448 mL/bag [(A solution 456 mL, B solution 788 mL, C solution 204 mL) x 4], 1904 mL/bag [(A solution 600 mL, B solution 1036 mL, C solution 268 mL) x 4]

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.